CLINICAL TRIALS PROFILE FOR SELETRACETAM
✉ Email this page to a colleague
Clinical Trials for Seletracetam
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00152451 ↗ | Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures | Completed | UCB Pharma | Phase 2 | This trial will evaluate the efficacy and safety of ucb 44212 as add on therapy in subjects with focal epilepsy. |
NCT00152503 ↗ | Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam | Completed | UCB Pharma | Phase 2 | This trial will evaluate the efficacy and safety of ucb 44212 as add-on therapy in subjects with focal epilepsy. |
NCT00175851 ↗ | Open Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of Epilepsy | Withdrawn | UCB Pharma | Phase 3 | This is a safety and efficacy study of add-on therapy with seletracetam in epilepsy patients who have participated in a previous seletracetam study |
NCT00175864 ↗ | Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy. | Withdrawn | UCB Pharma | Phase 3 | This is a safety and efficacy study of add on therapy with seletracetam in patients experiencing refractory epilepsy. |
NCT00422110 ↗ | A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures | Withdrawn | UCB Pharma | Phase 2/Phase 3 | This study will evaluate the effectiveness and safety of seletracetam when it is used in addition to other anti-epileptic medications by patients with partial onset seizures. It will also help to determine the best dose to use. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Seletracetam
Condition Name
Clinical Trial Locations for Seletracetam
Trials by Country
Clinical Trial Progress for Seletracetam
Clinical Trial Phase
Clinical Trial Sponsors for Seletracetam
Sponsor Name